Cargando…
Apelin and pulmonary hypertension
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by pulmonary vasoconstriction, pulmonary arterial remodeling, abnormal angiogenesis and impaired right ventricular function. Despite progress in pharmacological therapy, there is still no cure for PAH. The peptide apelin an...
Autores principales: | Andersen, Charlotte U., Hilberg, Ole, Mellemkjær, Søren, Nielsen-Kudsk, Jens E., Simonsen, U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224425/ https://www.ncbi.nlm.nih.gov/pubmed/22140623 http://dx.doi.org/10.4103/2045-8932.87299 |
Ejemplares similares
-
NT-proBNP <95 ng/l can exclude pulmonary hypertension on echocardiography at diagnostic workup in patients with interstitial lung disease
por: Andersen, Charlotte, et al.
Publicado: (2016) -
Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
por: Su, Junjing, et al.
Publicado: (2017) -
Levosimendan in pulmonary hypertension and right heart
failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018) -
Switching from sildenafil to riociguat for the treatment of PAH and inoperable CTEPH: Real-life experiences
por: Andersen, Asger, et al.
Publicado: (2017) -
Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy
por: Andersen, Asger, et al.
Publicado: (2022)